Online citations, reference lists, and bibliographies.
← Back to Search

Enhanced Oral Bioavailability Of Felodipine From Solid Lipid Nanoparticles Prepared Through Effervescent Dispersion Technique

Yingmeng He, Chenglin Zhan, Chao Pi, Y. Zuo, Siyun Yang, M. Hu, Yuntian Bai, Ling Zhao, Yumeng Wei
Published 2020 · Chemistry, Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Felodipine (FLD), a dihydropyridine calcium channel blocker with excellent antihypertensive effect, is poorly soluble and undergoes extensive hepatic metabolism, which lead to poor oral bioavailability (about 15%) and limit its clinic application. The goal of this study was to develop solid lipid nanoparticles (SLNs) loading FLD to improve the oral bioavailability. The FLD loaded solid lipid nanoparticles (FLD-SLNs) were prepared by the effervescent dispersion technique developed by our laboratory, which might have some advantages over traditional methods. The FLD-SLNs showed desired particle characteristics with particle size (198.15 ± 1.82 nm), poly dispersity index (0.26 ± 0.02), zeta-potential (− 25.53 ± 0.60 mV), entrapment efficiency (95.65 ± 0.70%), drug loading (2.33 ± 0.10%), and a spherical appearance. Pharmacokinetic results showed that the FLD-SLNs presented 3.17-fold increase in area under the curve (AUC (0-t) ) compared with free FLD after oral administration in beagle dogs, which indicated that SLNs prepared using the effervescent dispersion technique can improve the bioavailability of lipophilic drugs like felodipine by enhancement of absorption and reduction first-pass metabolism.
This paper references
10.3390/pharmaceutics8030025
Influence of the Encapsulation Efficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes
S. Ong (2016)
10.15171/apb.2015.043
Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.
Neda Naseri (2015)
10.3390/molecules21010116
Skin Delivery and in Vitro Biological Evaluation of Trans-Resveratrol-Loaded Solid Lipid Nanoparticles for Skin Disorder Therapies
R. B. Rigon (2016)
10.1016/j.colsurfb.2012.04.027
Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
S. Chalikwar (2012)
10.1016/j.ejps.2019.105159
Lipid-Based Nanocarriers for delivery of Small interfering RNA for therapeutic use.
D. Parashar (2019)
Lipospheres for controlled delivery of substances. United States Patent
A J Domb (1993)
10.1016/j.ijpharm.2006.11.004
Development and evaluation of nitrendipine loaded solid lipid nanoparticles: influence of wax and glyceride lipids on plasma pharmacokinetics.
V. V. Kumar (2007)
10.1007/s13204-012-0188-3
Nanosuspension for enhancement of oral bioavailability of felodipine
B. Sahu (2013)
10.2147/IJN.S51578
Nanoemulsion improves the oral bioavailability of baicalin in rats: in vitro and in vivo evaluation
L. Zhao (2013)
10.1016/J.CCLET.2018.11.015
Permeation into but not across the cornea: Bioimaging of intact nanoemulsions and nanosuspensions using aggregation-caused quenching probes
Dailei Liu (2018)
10.1007/s13346-018-0489-5
Assessment of improved buccal permeation and bioavailability of felodipine microemulsion-based cross-linked polycarbophil gel
M. Singh (2018)
SOLID LIPID NANOPARTICLES: AN ADVANCED DRUG DELIVERY SYSTEM
R. Reddy (2013)
10.1016/j.apsb.2018.05.004
Development of carrier-free nanocrystals of poorly water-soluble drugs by exploring metastable zone of nucleation
Xiaoting Ren (2019)
Formulation optimization of indomethacin-loading solid lipid nanoparticles by boxBehnken response surface methodology
C Kai (2016)
10.4103/0973-1296.133286
An attempt to stabilize tanshinone IIA solid dispersion by the use of ternary systems with nano-CaCO3 and poloxamer 188
Hong-Mei Yan (2014)
10.1016/S0378-5173(96)04822-3
Sterilization and freeze-drying of drug-free and drug-loaded solid lipid nanoparticles
R. Cavalli (1997)
10.1016/S0169-409X(01)00105-3
Solid lipid nanoparticles: production, characterization and applications.
W. Mehnert (2001)
Dissolution profile study on the novel doxycycline hydrochloride sustained-release capsules.
S. Yang (2014)
Microencapsulation of metoprolol tartrate into chitosan for 170 Page 9 of 10 AAPS PharmSciTech (2020) 21:170 improved oral administration and patient compliance
L Ochiuz (2013)
10.1038/nrd2197
Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs
C. H. Porter (2007)
10.4103/0975-1483.83765
Formulation and Evaluation of Solid Lipid Nanoparticles of Ramipril
P. Ekambaram (2011)
10.1111/j.2042-7158.2010.01184.x
Preparation and the in‐vivo evaluation of paclitaxel liposomes for lung targeting delivery in dogs
L. Zhao (2011)
10.1016/j.nano.2011.08.016
Solid lipid nanoparticles loading candesartan cilexetil enhance oral bioavailability: in vitro characteristics and absorption mechanism in rats.
Zhiwen Zhang (2012)
10.2174/1574886310666150514114619
Pharmacology, Efficacy and Safety of Felodipine with a Focus on Hypertension and Angina Pectoris.
Kinjal Navadiya (2015)
10.1016/j.drudis.2016.09.024
In vivo fate of lipid-based nanoparticles.
J. Qi (2017)
10.1155/2013/624841
Comparison of Various Generations of Superporous Hydrogels Based on Chitosan-Acrylamide and In Vitro Drug Release
Shikha Bhalla (2013)
10.1016/j.nano.2015.06.013
Environment-responsive aza-BODIPY dyes quenching in water as potential probes to visualize the in vivo fate of lipid-based nanocarriers.
X. Hu (2015)
10.1016/j.ijbiomac.2018.02.041
Polymer blends used to develop felodipine-loaded hollow microspheres for improved oral bioavailability.
Chao Pi (2018)
10.1016/j.ejpb.2016.10.022
Improved anti‐hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation
N. Dudhipala (2017)
10.37285/ijpsn.2015.8.4.1
Preparation, Characterization and in vivo Evaluation of Felodipine Solid-Lipid Nanoparticles for Improved Oral Bioavailability
Usha Kiranmai Gondrala (2015)
Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations
10.37285/ijpsn.2011.4.3.7
Valsartan Loaded Solid Lipid Nanoparticles: Development, Characterization, and In vitro and Ex vivo Evaluation
B. Parmar (2011)
10.1007/s12272-013-0181-8
Paclitaxel targeting to lungs by way of liposomes prepared by the effervescent dispersion technique
Y. Wei (2014)
10.1007/BF00878548
Vascular selective calcium entry blockers in the treatment of cardiovascular disorders: Focus on felodipine
W. Little (2004)
10.1016/j.drudis.2019.09.018
Ionic liquids: green and tailor-made solvents in drug delivery.
W. Huang (2019)
10.1016/j.addr.2007.09.007
Lipid-based delivery systems and intestinal lymphatic drug transport: A mechanistic update☆
Natalie L Trevaskis (2008)
10.1007/s13318-013-0158-5
Preparation and in vitro/in vivo evaluation of felodipine nanosuspension
B. Sahu (2013)
10.3109/03639045.2013.819885
Enhanced oral bioavailability of felodipine by naringenin in Wistar rats and inhibition of P-glycoprotein in everted rat gut sacs in vitro
M. Surya Sandeep (2014)
10.1021/IE402625H
Microencapsulation of Metoprolol Tartrate into Chitosan for Improved Oral Administration and Patient Compliance
L. Ochiuz (2013)
10.1208/s12249-019-1468-y
Preparation and Comparison of Oral Bioavailability for Different Nano-formulations of Olaparib
Akshay D Pathade (2019)
10.1016/j.cis.2019.102048
Carotenoid-loaded nanocarriers: A comprehensive review.
Abdur Rehman (2019)
10.3109/10611861003801859
Solid dispersion and effervescent techniques used to prepare docetaxel liposomes for lung-targeted delivery system: in vitro and in vivo evaluation
L. Zhao (2011)
10.1016/j.msec.2019.03.060
Optimization by design of etoposide loaded solid lipid nanoparticles for ocular delivery: Characterization, pharmacokinetic and deposition study.
I. Ahmad (2019)
10.1016/j.ijpharm.2013.08.076
Effect of freeze-drying, cryoprotectants and storage conditions on the stability of secondary structure of insulin-loaded solid lipid nanoparticles.
S. Soares (2013)
10.1016/j.addr.2019.06.006
Hybrid drug nanocrystals.
Yi Lu (2019)
10.1016/j.apsb.2019.01.009
Editorial: Persistent endeavors for the enhancement of dissolution and oral bioavailability
Wei Wu (2019)
10.1039/c5nr07474f
Evidence does not support absorption of intact solid lipid nanoparticles via oral delivery.
Xiongwei Hu (2016)
10.3109/02652048.2016.1144819
Highly water-soluble mast cell stabiliser-encapsulated solid lipid nanoparticles with enhanced oral bioavailability
Ravi R. Patel (2016)
10.1016/J.BEJ.2015.09.022
Biosynthesis of FeS nanoparticles from contaminant degradation in one single system
X. Xiao (2016)
Lipospheres for controlled delivery of substances
AJ Domb (1993)
10.1517/17425247.2011.604311
Solid lipid nanoparticles: an oral bioavailability enhancer vehicle
H. Harde (2011)
10.1016/J.IJPHARM.2006.11.057
Structural and thermal characterization of glyceryl behenate by X-ray diffraction coupled to differential calorimetry and infrared spectroscopy.
J. Brubach (2007)
10.21746/IJCLS.2017.6.1
Solid dispersion as a formulation strategy: A mini review
P. Patel (2019)
10.3109/10717541003762839
In vitro and in vivo studies of lipid-based nanocarriers for oral N3-o-toluyl-fluorouracil delivery
C. Liu (2010)
10.1016/j.ijpharm.2008.03.030
Studies on PEG-modified SLNs loading vinorelbine bitartrate (I): preparation and evaluation in vitro.
F. Wan (2008)
10.1517/17425247.2014.945416
Optimization of nanostructured lipid carriers of lamotrigine for brain delivery: in vitro characterization and in vivo efficacy in epilepsy
Tausif Alam (2015)
10.1208/s12249-017-0944-5
Enhancement of In Vivo Efficacy and Oral Bioavailability of Aripiprazole with Solid Lipid Nanoparticles
Silki (2017)
efficacy and safety of felodipine with a focus on hypertension and angina pectoris
K Navadiya (2015)
Development and evaluation of felodipine sustained-release tablets
JY Yuan (2018)
10.18632/oncotarget.19984
Pharmacokinetics and drug-drug interaction between enalapril, enalaprilat and felodipine extended release (ER) in healthy subjects
D. Li (2017)
10.7897/2230-8407.04831
ANESTHETIC EFFICACY OF COMBINATION OF TWO PERCENT LIDOCAINE WITH 1:80,0 00 EPINEPHRINE AND 0.5 MOL/L MANNITOL FOR INFERIOR ALVEOLAR NERVE BLOCKS IN PATIENTS WITH SYMPTOMATIC IRREVERS IBLE PULPITIS: AN IN VIVO STUDY
B. ThimmaiahP (2013)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar